MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 11-10-2022
Viveve Medical Retained Earnings 2011-2026 | VIVE
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Viveve Medical
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -242 M | - | -198 M | -155 M | -106 M | -68.6 M | -48.5 M | -36.1 M | -104 M | -107 M | -98.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -36.1 M | -242 M | -116 M |
Quarterly Retained Earnings Viveve Medical
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -259 M | -254 M | -248 M | -242 M | -236 M | -230 M | -226 M | -220 M | -220 M | -220 M | -220 M | -198 M | -198 M | -198 M | -198 M | -155 M | -155 M | -155 M | -155 M | -106 M | -106 M | -106 M | -106 M | -68.6 M | -68.6 M | -68.6 M | -68.6 M | -48.5 M | -48.5 M | -48.5 M | -48.5 M | -36.1 M | -36.1 M | -36.1 M | -36.1 M | -29.9 M | 29.9 M | -104 M | -104 M | -107 M | -107 M | -107 M | -107 M | -98.7 M | -98.7 M | -98.7 M | -98.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 29.9 M | -259 M | -129 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Tactile Systems Technology
TCMD
|
54.9 M | $ 26.39 | -1.46 % | $ 604 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Tandem Diabetes Care
TNDM
|
-1.25 B | $ 21.64 | -7.2 % | $ 1.47 B | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 35.8 | -2.29 % | $ 1.11 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-374 M | $ 2.21 | -2.64 % | $ 130 M |  Israel |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
NanoVibronix
NAOV
|
-69.8 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 24.35 | -0.41 % | $ 206 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Viemed Healthcare
VMD
|
103 M | $ 9.26 | 0.43 % | $ 360 M | USA |
 |
Varex Imaging Corporation
VREX
|
-5.9 M | $ 10.78 | - | $ 446 M | USA |
 |
Outset Medical
OM
|
-1.17 B | $ 3.39 | -3.69 % | $ 51.6 K | USA |
 |
Vivos Therapeutics
VVOS
|
-104 M | $ 1.17 | -2.03 % | $ 5.87 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.61 | 0.82 % | $ 33.2 M | USA |
 |
Aethlon Medical
AEMD
|
-168 M | $ 2.26 | -0.44 % | $ 3.53 M | USA |
 |
PAVmed
PAVM
|
-294 M | $ 8.77 | -1.9 % | $ 63.4 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
InspireMD
NSPR
|
-302 M | $ 1.67 | -3.47 % | $ 107 M | Israel |
 |
Beyond Air
XAIR
|
-286 M | $ 0.67 | -2.84 % | $ 45.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 11.25 | -1.4 % | $ 1.52 B | USA |
 |
Penumbra
PEN
|
238 M | $ 335.34 | -0.32 % | $ 13.1 B | USA |
 |
Zimmer Biomet Holdings
ZBH
|
11.1 B | $ 87.82 | -1.49 % | $ 17.8 B | USA |
 |
MiMedx Group
MDXG
|
-42.7 M | $ 3.82 | -3.05 % | $ 565 M | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
-205 M | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
-119 M | $ 0.68 | -0.31 % | $ 28.5 M | USA |
 |
TELA Bio
TELA
|
-398 M | $ 0.64 | -14.68 % | $ 30 M | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 49.12 | -2.54 % | $ 1.44 B | USA |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.2 | -3.33 % | $ 48.8 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |